Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
European Journal of Nuclear Medicine and Molecular Imaging|July 10, 2023
Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trialAdrien Holzgreve, Marcus Unterrainer, Jérémie Calais, et al.
EJNMMI Reports|August 18, 2024
PSMA-PET/CT response after metastasis-directed radiotherapy of bone oligometastases in prostate cancerGabriel T Sheikh, Christian Trapp, Nina-Sophie Schmidt-Hegemann, et al.
European Radiology|May 20, 2024
Validation of the standardization framework SSTR-RADS 1.0 for neuroendocrine tumors using the novel SSTR‑targeting peptide [<sup>18</sup>F]SiTATER Ebner, A Lohse, M P Fabritius, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 28, 2025
Randomized Phase 2 Trial of an Extended and Flexible Dosing Schedule of <sup>177</sup>Lu-PSMA Molecular Radiotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT): Study ProtocolAdrien Holzgreve, Astrid Delker, Zachary Ells, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2024
PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide [<sup>18</sup>F]SiTATE - first clinical experiencesSophie C Kunte, Vera Wenter, Johannes Toms, et al.
Biomedicines|April 23, 2022
Longitudinal [<sup>18</sup>F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse ModelAdrien Holzgreve, Dennis Pötter, Matthias Brendel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 5, 2026
Initial Clinical Experience with [<sup>177</sup>Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and DosimetryLisa Glantschnig, Johanna S Enke, Bradley W Schuller, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 24, 2025
<sup>68</sup>Ga-FAPI and <sup>18</sup>F-FAPI PET/CT for detection of nodal metastases prior radical cystectomy in high-risk urothelial carcinoma patientsLena M Unterrainer, Hans P Schmid, Sophie C Kunte, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 9, 2024
Implementation of PET/CT in radiation oncology-a patterns-of-care analysis of the German Society of Nuclear Medicine and the German Society of Radiation OncologySimone Wegen, Ursula Nestle, Constantinos Zamboglou, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 11, 2026
Effects of androgen receptor signaling inhibitors on absorbed doses in mCRPC patients undergoing [<sup>177</sup>Lu]Lu-PSMA-617 or [<sup>177</sup>Lu]Lu-PSMA-I&T therapy: dosimetry resultsJosef Zahner, Astrid Delker, Zachary Ells, et al.
Pageof 12